CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-11 | Riley Jennifer Chief Strategy Officer | Sale | −2,655 | $19.59 | $52K | 37,041 |
| 2026-06-10 | Riley Jennifer Chief Strategy Officer | Shares withheld for taxes | −588 | $13.10 | $8K | 39,696 |
| 2026-05-21 | Riley Jennifer Chief Strategy Officer | Grant or award | +34,200 | 36,855 | ||
| 2026-02-26 | Riley Jennifer Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2025-12-10 | Riley Jennifer Chief Strategy Officer | Shares withheld for taxes | −637 | $4.10 | $3K | 2,655 |
| 2025-01-01 | Riley Jennifer Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 6 trades